Efficacy and safety of casirivimab-imdevimab combination on COVID-19 patients: A systematic review and meta-analysis randomized controlled trial

BACKGROUND: The advantages and disadvantages of casirivimab-imdevimab for coronavirus disease 2019 are not well understood. We conducted a systematic review and meta-analysis of relevant literature to determine the therapeutic effectiveness and potential side effects of casirivimab-imdevimab in COVI...

Descripción completa

Detalles Bibliográficos
Autores principales: Wicaksono, Imam Adi, Suhandi, Cecep, Elamin, Khaled M., Wathoni, Nasrul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696184/
http://dx.doi.org/10.1016/j.heliyon.2023.e22839

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10696184/
http://dx.doi.org/10.1016/j.heliyon.2023.e22839

Ejemplares similares